IIT Kanpur just cracked open one of vaccine science's most interesting puzzles.
Their scientists have mapped — atom by atom — how an experimental molecule called EP67 flips the switch on human immune cells to supercharge vaccines.
The study just dropped in PNAS. 🧬
And it could change how we design boosters for everything from COVID to future pandemics.
When a virus or bacteria attacks you, your body fires off a tiny protein called C5a.
Think of C5a as the immune system's war siren. 🚨
It wakes up your defenses. Rallies the troops. Gets you fighting back.
But there's a catch.
Too much C5a, for too long — and your own body starts burning down the house.
Inflammation. Tissue damage. Collateral chaos.
That's why your blood carries enzymes that chop C5a up the moment the threat is gone.
Professor Arun K. Shukla's lab at IIT Kanpur took that natural safety trick and ran with it.
They built a stripped-down mimic of C5a — just 10 amino acids long — that keeps the useful punch but skips the destruction.
That's EP67.
Stronger signal. Longer immunity. No inflammation hangover.
Exactly what a vaccine adjuvant is supposed to do.
Using the National cryo-EM Facility at IIT Kanpur, the team captured the first high-resolution snapshot of EP67 physically gripping its target receptor (C5aR1) on human immune cells.
A molecular handshake. Frozen in time.
That blueprint is a big deal because:
EP67 isn't a lab curiosity. It's been quietly stacking wins.
In mice, when added to vaccines against multiple viruses — including SARS-CoV-2 — animals mounted a stronger immune response and recovered faster than with the vaccine alone.
It's even shown surprise activity against bacterial infections and fungal pathogens.
One molecule. Multiple battlefields.
This wasn't outsourced research. It was built end-to-end in India — backed by ICMR, ANRF, DBT, and DST, and imaged on Indian cryo-EM infrastructure.
A homegrown blueprint. For a global problem.
The next generation of vaccines might not just be safer and stronger.
They might carry a fingerprint from Kanpur. 🚀
That's all for now!
